Skip to content
2000
Volume 8, Issue 4
  • ISSN: 1574-8847
  • E-ISSN: 2212-3938

Abstract

Amphetamine-like drugs are sympathomimetic agents with marked central and peripheral stimulant properties. Despite the street illegal drugs such as amphetamine and ecstasy, some amphetamine-like compounds are also legally marketed under medical prescription in the treatment of attention deficit-hyperactivity disorder (methylphenidate) and obesity/overweight (fenproporex and diethylpropione). However, similar with what happens with their illicit analogues, therapeutic amphetamine-like drugs also share important toxicological risks. Although methylphenidate is considered the first choice in the treatment of attention deficit-hyperactivity disorder, its high popularity among teenagers and children is raising concern in the medical community. Regarding weight-loss purposes, the use of amphetamine-like compounds are very controversial, though. Thus, the present review will address pharmacokinetic, pharmacodynamic, and toxicological aspects of amphetamine-like compounds used with therapeutic aims.

Loading

Article metrics loading...

/content/journals/ccp/10.2174/15748847113089990052
2013-11-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/ccp/10.2174/15748847113089990052
Loading

  • Article Type:
    Research Article
Keyword(s): amphepramone; Amphetamine; diethylpropione; fenproporex; methylphenidate; stimulants
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test